Pediatric Rheumatology

unofficial impact factor 1.74

Open Access Highly Access

Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report

Robert J Brogan*, Despina Eleftheriou, James Gnanapragasam, Nigel J Klein and Paul A Brogan

Pediatric Rheumatology 2009, 7:3 doi:10.1186/1546-0096-7-3

Accesses  

  • Last 30 days: 56 accesses
  • Last 365 days: 805 accesses
  • All time: 3741 accesses